Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,831 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
Cognetti DM, Johnson JM, Curry JM, Kochuparambil ST, McDonald D, Mott F, Fidler MJ, Stenson K, Vasan NR, Razaq MA, Campana J, Ha P, Mann G, Ishida K, Garcia-Guzman M, Biel M, Gillenwater AM. Cognetti DM, et al. Among authors: ishida k. Head Neck. 2021 Dec;43(12):3875-3887. doi: 10.1002/hed.26885. Epub 2021 Oct 9. Head Neck. 2021. PMID: 34626024 Free PMC article. Clinical Trial.
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.
Tahara M, Okano S, Enokida T, Ueda Y, Fujisawa T, Shinozaki T, Tomioka T, Okano W, Biel MA, Ishida K, Hayashi R. Tahara M, et al. Among authors: ishida k. Int J Clin Oncol. 2021 Oct;26(10):1812-1821. doi: 10.1007/s10147-021-01960-6. Epub 2021 Jun 24. Int J Clin Oncol. 2021. PMID: 34165660 Free PMC article. Clinical Trial.
Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma.
Sakurai A, Yamaguchi K, Ishida K, Horikawa N, Kawai E, Kotani Y, Yoshida T, Kishimoto N, Tatsumi K, Okudate M, Iemura Y, Taga Y, Aki M, Ando Y, Yanai A, Yamanoi K, Taki M, Murakami R, Hamanishi J, Mandai M. Sakurai A, et al. Among authors: ishida k. Int J Clin Oncol. 2025 Jan 8. doi: 10.1007/s10147-024-02687-w. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39779654
Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck.
Sugiyama N, Yamada S, Nakamura Y, Morita K, Kano K, Ishida K, Takeuchi K, Kita JY, Sahara S, Sugawara K, Nagai KI, Matsuda S, Hayashi A, Makoshi Y, Mochizuki D, Nakanishi H, Imai A, Takizawa Y, Misawa Y, Misawa K. Sugiyama N, et al. Among authors: ishida k. Anticancer Res. 2025 Jan;45(1):81-95. doi: 10.21873/anticanres.17395. Anticancer Res. 2025. PMID: 39740827
Impact of radiotherapy-related late toxicities of skin and soft tissue in the neck on quality of life in head and neck cancer patients: a multi-institutional observational study in Japan.
Higashino T, Wakabayashi M, Zenda S, Yasunaga Y, Araki J, Mukaigawa T, Onitsuka T, Nakagawa M, Hamahata A, Narita K, Arikawa M, Takanari K, Kadota H, Yanagisawa D, Tanaka K, Matsumoto H, Kimata Y, Miyamoto S, Sakuraba M, Kawai K, Terao Y, Hyodo I, Ishida K, Yoshimura K. Higashino T, et al. Among authors: ishida k. Support Care Cancer. 2024 Dec 30;33(1):64. doi: 10.1007/s00520-024-09128-4. Support Care Cancer. 2024. PMID: 39738887
2,831 results